Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company (WBA)

Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company (WBA) Healthcare & Pipeline Overview

Walgreens Boots Alliance, Inc. is a pharmacy-led health and beauty retail company operating in the United States and internationally. With a focus on prescription drugs, health and wellness products, and retail services, WBA leverages its extensive store network and online platforms to serve diverse customer needs in a competitive healthcare market.

What Is the Investment Thesis for WBA?

Walgreens Boots Alliance faces a challenging environment with a negative profit margin of -2.8% and a market capitalization of $10.37B as of May 10, 2026. The company's dividend yield of 2.09% may attract income-focused investors. Growth catalysts include expanding healthcare service offerings within its retail locations and further developing its online platforms to enhance customer reach. However, potential risks include increased competition from online pharmacies and evolving healthcare regulations that could impact profitability. The company's beta of 0.77 suggests lower volatility compared to the broader market. Success hinges on WBA's ability to adapt to changing consumer preferences and navigate the complex healthcare landscape effectively.

Based on FMP financials and quantitative analysis

WBA Key Highlights

• Market Cap of $10.37B indicates the overall value of the company in the stock market.
• Profit Margin of -2.8% reflects the company's profitability challenges.
• Gross Margin of 17.3% shows the percentage of revenue remaining after deducting the cost of goods sold.
• Beta of 0.77 suggests that the stock is less volatile than the market average.
• Dividend Yield of 2.09% provides a return to investors in the form of dividend payments.

Who Are WBA's Competitors?

WBA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are WBA's Key Strengths?

• Strong brand recognition with Walgreens and Boots.
• Extensive network of retail locations.
• Established supply chain and distribution capabilities.
• Experienced pharmacy professionals.

What Are WBA's Weaknesses?

• Negative profit margin.
• High debt levels.
• Dependence on prescription drug sales.
• Exposure to regulatory changes.

What Could Drive WBA Stock Higher?

• Expansion of healthcare service offerings within retail locations to drive revenue growth.
• Development of online platforms to enhance customer reach and convenience.
• Strategic partnerships with healthcare providers and insurance companies to expand service offerings.

What Are the Key Risks for WBA?

• Negative return on equity (-42.4%) — the business is not currently generating profit on shareholder capital.
• Insider selling — insiders were net sellers of roughly $61.3M recently.
• Increased competition from online pharmacies impacting market share.
• Evolving healthcare regulations and reimbursement models affecting profitability.
• Drug pricing pressures reducing margins.
• High debt levels creating financial strain.

What Are the Growth Opportunities for WBA?

• Expansion of Healthcare Services: Walgreens Boots Alliance can expand its healthcare service offerings within its retail locations, such as providing vaccinations, health screenings, and chronic disease management programs. This can drive increased foot traffic and revenue growth. The market for healthcare services at retail locations is estimated to reach $265 billion by 2028, offering a significant opportunity for WBA to capture a larger share. Timeline: Ongoing.
• Development of Online Platforms: WBA can further develop its online platforms, including boots.com and its integrated mobile application, to enhance customer reach and convenience. This includes offering online prescription refills, virtual consultations, and personalized product recommendations. The global e-pharmacy market is projected to reach $177.79 billion by 2026, presenting a substantial growth opportunity. Timeline: Ongoing.
• Strategic Partnerships: Forming strategic partnerships with healthcare providers, insurance companies, and technology companies can enhance WBA's service offerings and expand its customer base. These partnerships can facilitate integrated care models, data sharing, and innovative solutions. The market for healthcare partnerships is growing rapidly, with an estimated value of $1.5 trillion by 2027. Timeline: Ongoing.
• International Expansion: WBA can expand its presence in international markets, particularly in emerging economies with growing healthcare needs. This includes opening new retail stores, establishing partnerships with local pharmacies, and adapting its product offerings to meet local preferences. The global pharmaceuticals market is expected to reach $1.57 trillion by 2028, offering significant growth opportunities. Timeline: Ongoing.
• Personalized Healthcare Solutions: WBA can leverage data analytics and technology to offer personalized healthcare solutions to its customers. This includes providing tailored medication recommendations, customized wellness programs, and proactive health alerts. The market for personalized medicine is projected to reach $4.38 trillion by 2030, presenting a substantial growth opportunity for WBA to differentiate itself and enhance customer loyalty. Timeline: Ongoing.

What Opportunities Does WBA Have?

• Expansion of healthcare services within retail locations.
• Development of online platforms and virtual care services.
• Strategic partnerships with healthcare providers and insurers.
• International expansion in emerging markets.

What Threats Does WBA Face?

• Increased competition from online pharmacies.
• Evolving healthcare regulations and reimbursement models.
• Economic downturn impacting consumer spending.
• Drug pricing pressures.

What Are WBA's Competitive Advantages?

• Extensive Retail Network: WBA has a large network of retail stores in the United States and internationally, providing convenient access to healthcare products and services.
• Brand Recognition: The Walgreens and Boots brands are well-known and trusted by consumers.
• Pharmacy Expertise: WBA has a team of experienced pharmacists who provide medication counseling and other pharmacy services.
• Supply Chain Efficiency: WBA has a well-established supply chain that ensures efficient distribution of products to its stores.

What Does WBA Do?

Walgreens Boots Alliance, Inc. (WBA) was founded in 1901 and is headquartered in Deerfield, Illinois. The company operates as a pharmacy-led health and beauty retail corporation, serving customers through its two primary segments: the United States and International. In the United States, WBA sells prescription drugs and a wide array of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise items through its retail drugstores. It also offers central specialty pharmacy services and mail services. As of August 31, 2021, the United States segment operated 8,965 retail stores under the Walgreens and Duane Reade brands, along with five specialty pharmacies. Internationally, WBA sells prescription drugs, health and wellness products, beauty products, personal care items, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices. These operations are conducted via boots.com and an integrated mobile application. The International segment also engages in pharmaceutical wholesaling and distribution in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada brands in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile, along with 548 optical practices, including 160 on a franchise basis. WBA's business model is centered on providing accessible and convenient healthcare and retail solutions to its customers globally.

What Products and Services Does WBA Offer?

• Operates retail drugstores under the Walgreens and Duane Reade brands in the United States.
• Sells prescription drugs and an assortment of retail products, including health, wellness, beauty, and personal care items.
• Provides central specialty pharmacy services and mail services.
• Operates retail stores under the Boots, Benavides, and Ahumada brands internationally.
• Sells health and wellness, beauty, personal care, and other consumer products through its pharmacy-led retail stores and optical practices.
• Engages in pharmaceutical wholesaling and distribution business in Germany.

How Does WBA Make Money?

• Generates revenue from the sale of prescription drugs and retail products in its stores.
• Provides pharmacy services, including prescription filling, medication counseling, and immunizations.
• Offers specialty pharmacy services for patients with complex medical conditions.
• Operates online platforms for e-commerce and virtual healthcare services.

What Industry Does WBA Operate In?

Walgreens Boots Alliance operates in the competitive medical pharmaceuticals industry, characterized by evolving consumer preferences, technological advancements, and regulatory changes. The industry is experiencing growth in demand for prescription drugs, health and wellness products, and convenient healthcare services. WBA competes with other pharmacy chains, online retailers, and healthcare providers. The company's success depends on its ability to differentiate itself through superior customer service, innovative product offerings, and efficient supply chain management. The market is also influenced by factors such as aging populations, increasing healthcare costs, and the rise of personalized medicine.

Who Are WBA's Key Customers?

• Individual consumers seeking prescription medications and over-the-counter healthcare products.
• Patients with chronic conditions requiring ongoing medication management and support.
• Healthcare providers and institutions purchasing pharmaceuticals and medical supplies.
• Beauty and personal care enthusiasts seeking a wide range of products.

WBA Valuation & Market Position

With a $10.37B market cap, Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company sits in the large-cap segment of the market. Relative to its peer group, WBA's quantitative score of 45/100 is roughly in line with the peer average of 48/100.

FY2026 estForward Outlook

Wall Street analysts project Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company revenue of about $155.99B for fiscal 2026, with EPS near $1.57. The estimate reflects 7 contributing analysts.

F-Score 4/9Financial Health

Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.30 places it in the grey zone, a middle ground that warrants monitoring.

ROE -42%Key Financial Metrics

Return on equity for Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company stands at -42.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -4.4%, showing how much profit it generates from its asset base. Its free cash flow yield is -0.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.60 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -29.2%, the inverse of the P/E and a quick read on earnings relative to price.

Net sellingInsider Activity

The most recent 12 insider filings for Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company break down as 12 sales and 0 purchases. On net that is roughly 4.0M shares disposed (about $61.3M), a signal worth weighing alongside the fundamentals.

WBA Financials

WBA Latest News

WBA Analyst Consensus

WBA MoonshotScore

WBA Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources